Ovarian carcinoma therapy with monoclonal antibodies.
Canevari
S
S
Experimental Oncology E, Istituto Nazionale Tumori, Milan, Italy.
Miotti
S
S
Bottero
F
F
Valota
O
O
Colnaghi
M I
MI
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor / Q000276:immunology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D010051:Ovarian Neoplasms / Q000276:immunology / Q000628:therapy*; D016499:Radioimmunotherapy
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor